SCHEMBL24355264

SCHEMBL24355264

CS(=O)(=O)Nc1cc(I)cc(C(F)(F)F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 5/20 0.51
BRD4 O60885 1/20 0.47
NPY5R Q15761 1/20 0.40
PPARG P37231 1/20 0.39
GAA P10253 1/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A3 Q01959 2/20 0.39
P2RX1 P51575 1/20 0.38
EPHX2 P34913 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
MAPT P10636 1/20 0.38
ACP1 P24666 1/20 0.37
KEAP1 Q14145 1/20 0.37
FFAR1 O14842 1/20 0.37
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CDK7 P50613 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12054671 0.87 KIF11 (0.59) KIF11BRD4NPY5RPPARGGAA
SCHEMBL16658370 0.81 KIF11 (0.53) KIF11BRD4NPY5RPPARGP2RX1
SCHEMBL15218437 0.81 KIF11 (0.53) KIF11BRD4NPY5RPPARGGAA
SCHEMBL397354 0.79 KIF11 (0.51) KIF11BRD4NPY5RPPARGGAA
SCHEMBL1410405 0.79 ACP1 (0.52) KIF11BRD4NPY5RPPARGGAA
SCHEMBL13130516 0.78 KIF11 (0.50) KIF11BRD4NPY5RPPARGGAA
SCHEMBL16715359 0.77 PPARG (0.50) KIF11BRD4NPY5RPPARGGAA
SCHEMBL4169754 0.77 BRD4 (0.43) KIF11BRD4MAPTKEAP1
SCHEMBL15648605 0.76 KIF11 (0.48) KIF11BRD4NPY5RPPARGGAA
SCHEMBL2875965 0.74 KIF11 (0.47) KIF11BRD4GAAP2RX1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022083657-A1 SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 苏州泽璟生物制药股份有限公司 2022-04-28 WO disclosed